Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
The Lancet. Oncology.
Times cited: 1
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
European journal of cancer (Oxford, England : 1990).
Times cited: 25
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 146